Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
John T. Patton, Mark E. Lustberg, Gerard Lozanski, Sabrina L. Garman, William H. Towns, Callie M. Drohan, Amy Lehman, Xiaoli Zhang, Brad Bolon, Li Pan, A. Douglas Kinghorn, Michael R. Grever, David M. Lucas, Robert A. Baiocchi
Published Jun 12, 2014 · Vol. 6, No. 5 · pp. 2693-2708
Scott A. Ezell, Michele Mayo, Teeru Bihani, Suprawee Tepsuporn, Suping Wang, Melissa Passino, Shaun E. Grosskurth, Mike Collins, Julie Parmentier, Corinne Reimer, Kate F. Byth
Published Jun 7, 2014 · Vol. 5, No. 13 · pp. 4990-5001
Sylvia Müller, Yuan Chen, Torsten Ginter, Claudia Schäfer, Marc Buchwald, M. Lienhard Schmitz, Jana Klitzsch, Alexander Schütz, Andrea Haitel, Katharina Schmid, Richard Moriggl, Lukas Kenner, Karlheinz Friedrich, Claude Haan, Iver Petersen, Thorsten Heinzel, Oliver H. Krämer
Published Apr 12, 2014 · Vol. 5, No. 10 · pp. 3184-3196